RSS

antibacterial

Antabio — a biopharma specialising in the development of novel antibacterial treatments — has extended its Series A financing round with an additional €5.2 million from new investors to add to the €7.3 million raised in the first closing last year. more

News

A position paper released by the BEAM Alliance is calling for worldwide stakeholders to support small and medium-sized enterprise (SME)-driven innovation into reviving the product pipeline to fight antimicrobial resistance (AMR). more

News